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The aim of this study was to present the implications of the use of herbs during pregnancy, pointing 
out those that should be avoided during this condition because of their abortifacient and/or teratogenic 
potential. We carried out searches in the databases ScienceDirect, Scielo and Google Scholar, adopting 
as criteria for inclusion: book chapters and/or complete articles (with abstract), available in English, 
Portuguese or Spanish, published from 1996 to in 2011. After a pre-selection of 83 articles, 49 
bibliographies were used in the manufacturing end of the article, where 25 were from the Scielo database, 
18 from ScienceDirect and 6 from Google Scholar. From the articles studied, we identified the four most 
commonly used plants as emmenagogue/abortifacient agents by patients of the Department of Prenatal 
SUS: senne, arruda, boldo and buchinha-do-norte or cabacinha. Thus, we conclude that people often 
adhere to the maxim “if it’s natural, it does no harm” in their rational use of natural products, without the 
right guidance, believing that these products are safe to use. This usage is even more worrisome among 
the elderly, pregnant women and children. Regarding the safety of these products, some information and 
reliable data are scarce or contradictory.
Uniterms: Medicinal plants/undue use/pregnancy. Medicinal plants/teratogenic activity. Medicinal plants/
emmenagogue/abortifacient agents. Natural products/adverse effects. Herbal medicines/adverse effects.
Este trabalho busca as implicações atuais sobre o uso de plantas medicinais durante a gravidez, alertando 
sobre aquelas que devem ser evitadas nesse período por serem potencialmente abortivas e/ou teratogênicas. 
Para tanto, foram realizadas buscas nas bases de dados Sciencedirect, Scielo e Google scholar, adotando-
se como critérios de inclusão capítulos de livros e/ou artigos completos (com abstract) e disponíveis, 
em português, inglês ou espanhol, publicados de 1996 a 2011. Após uma pré-seleção de 83 artigos, 49 
bibliografias foram utilizadas na confecção final do artigo, sendo 25 provenientes da base de dados Scielo, 
18 do Sciencedirect e 06 do Google scholar. A partir dos artigos estudados, identificaram-se as quatro 
plantas mais utilizadas como emenagogas/abortivas por pacientes do Serviço de Pré-Natal do SUS: 
senne, arruda, boldo e buchinha-do-norte ou cabacinha. Assim, é possível concluir que, muitas vezes, a 
população se utiliza da máxima “se é natural, não faz mal” para fazer uso irracional de produtos naturais, 
sem a correta orientação, acreditando que esses produtos sejam incapazes de provocar qualquer dano. Esse 
uso é ainda mais preocupante quando realizado por idosos, gestantes e crianças. Em relação à segurança 
do uso desses produtos, algumas informações e dados confiáveis ainda são escassos ou contraditórios. 
Unitermos: Plantas medicinais/uso indevido/gravidez. Plantas medicinais/potencial teratogênico. Plantas 
medicinais/emenagogas/abortivas. Produtos naturais/efeitos adversos. Fitoterápicos/efeitos adversos.
INTRODUCTION
Since the dawn of human existence, cultures have 
used plants for the relief or cure of many different ailments 
(Amorim et al., 2003). Historical records of 5000 years 
show that the Sumerians had used herbs for medicinal 
purposes, and the first book on herbs on record dates back 
to 2700 BCE and comes from the Chinese with a list of 365 
plants (Biazzi, 2003). There are also records of medicinal 
plants in Syria and Egypt (1500 b.C) and India (1500-1400 
b.C), as well as evidence of their extensive use in North 
and South America by indigenous people (Fowler, 2006). 
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In Brazil, records of the use of medicinal plants date from 
the time of its discovery, but it is known that the Native 
Americans who already lived here had knowledge of thera-
peutic plants from the national flora (Reis et al., 2004).
It is easy to understand the reason for the use of old 
plants for medicinal purposes. Only after the industrial 
revolution and the advancement of organic chemistry, did 
synthetic products gain supremacy in pharmacological 
treatments (Lamb et al., 2005), but before that, natural 
products were practically the only treatment option for 
diseases that afflicted humanity. According to estimates 
by the World Health Organization (WHO), 80% of the 
world’s population uses the resources of popular medi-
cines to meet the needs of primary health care, which can 
circulate about 22 billion dollars annually (Costa et al., 
1998; Yunes et al., 2001).
In the United States alone, this market represents 
about US$ 5 billion per year, the industry’s fastest growing 
pharmaceutical market in the U.S. (Aschwanden, 2001). 
In Brazil, there are no official figures to date, but it is 
estimated that this market is around US$ 160 million per 
year (Carvalho et al., 2008).
Despite such widespread and ancient use of natural 
products, only since 1978 has the World Health Organiza-
tion officially recognized the use of herbal medicines for 
prophylactic, curative, palliative or diagnostic purposes, 
recommending the worldwide spread of the knowledge 
required for their use (Ministério da Saúde, 2001). The big 
problem is that these products are often used recklessly 
due to the belief that since they are natural, they are free 
of adverse reactions and toxic effects (Rates, 2001; Gallo, 
Koren, 2001).
In a survey conducted in Belo Horizonte (MG), 60% 
of the population said they did not believe that plants and 
herbal medicines have toxic effects (Oliveira, Gonçalves, 
2006). These results show that the idea of “natural, it does 
no harm” is a disturbing reality among users, and that ef-
fective measures are essential to focus on the rational use 
of medicinal plants and herbal medicines.
The lack of the minimum information necessary for 
the proper use of medicinal plants and herbal medicines 
makes them easy targets for self-medication without liabil-
ity (Alexander et al., 2005). The ignorance of consumers 
often reflects the little knowledge of health professionals. 
In fact, studies show that many doctors, nurses and phar-
macists are not adequately informed about the action, ef-
ficacy and safety of herbal medicines (Xu, Levine, 2008). 
Moreover, folklore and folk practices, rather than scientific 
studies, are often used as a means of obtaining information 
on indications, efficacy and safety of medicinal plants and 
herbal medicines (Alexander et al., 2005).
It should be noted that the medicinal plants used 
in herbal medicines contain xenobiotic agents, i.e., sub-
stances foreign to the human body, and as such, their 
biotransformation products can be potentially toxic. In 
addition to the immediate effects, which are readily cor-
related with their intake, effects that are established in the 
long-term may be asymptomatic, but can lead to a severe 
clinical picture, sometimes fatal (Lapa et al., 2004). It is 
possible to identify two types of adverse effects related to 
the use of medicinal plants. The first is considered intrinsic 
to these plants, where this toxicity may be related to an 
overdose and/or interaction with other drugs. The extrinsic 
one, however, is associated with the manufacture of the 
herbal product and problems such as incorrect identifica-
tion of a plant, lack of standardization in the preparation, 
contamination, adulteration, etc. In addition, other factors 
may interfere with the quality and therefore the merit of 
herbal therapy (Calixto, 2000).
In Brazil, in an attempt to streamline production 
and make the use of herbal medicines safer, legislation 
for these products has undergone changes in recent years. 
The National Health Surveillance Agency (ANVISA) 
is developing standards for their regulation, based on 
Ordinance No. 6, 1995, which set deadlines for the phar-
maceutical companies to submit data on the efficacy and 
safety of herbal medicines (Turolla, Nascimento, 2006). 
This concern of regulators with the standardization of 
herbal medicines facilitates the evaluation of important 
aspects such as efficacy and safety of these drugs, includ-
ing periods of pregnancy and lactation.
Pregnant women and mothers with infants, the popu-
lation that frequently uses these substances, also believe 
that they have no adverse reactions or toxic effects. Thus, 
they rarely seek information from health care professionals 
about herbal products (Clarke et al., 2007).
In the particular case of pregnant women, the use of 
any drug or product, either natural or synthetic, must al-
ways take into account the risk-benefit ratio (Sanseverino 
et al., 2001). In this condition, the woman’s metabolism 
and physiological characteristics are altered to focus 
almost exclusively on promoting the development of 
the new being carried in her womb, and there are several 
substances that can harm the developing fetus, especially 
when used in the first trimester of pregnancy. Even with 
all these restrictions, studies show that medication use by 
pregnant women is high. In 2002, Fonseca et al. demon-
strated the use of drugs in 94.6% of pregnant women par-
ticipating in the study, where 11.2% used self-medication 
or layman indication.
Another study by Mengue et al. (2004) assessed 
the situation in Brazil regarding the pattern of drug use 
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in the cities of Porto Alegre, Sao Paulo, Rio de Janeiro, 
Salvador, Fortaleza and Manaus. The results showed that 
83% of women reported having used some type of drug 
during pregnancy, with a positive association with level of 
education, age and the fact of having a companion; these 
findings are similar to other studies. According to these 
authors, the results suggested a situation in which drug 
use is elective, where the greater availability of resources 
would be a determinant for use. The women of higher 
socioeconomic status tend to use drugs more frequently 
compared to mothers with less schooling, young, single 
and with many children.
An Australian study showed that the use of me-
dicinal plants among pregnant women took second place 
(12%) among the different therapies used by these women 
(Pinn, Pallet, 2002).
The use of plant substances was also reported by 
36% of pregnant women in Oslo, Norway, with an aver-
age of 1.7 products per woman (Nordeng, Havnen, 2005). 
In the United States, a study of women from rural areas 
showed that of the 95.8% of the participants who used at 
least one type of medication, 92.8% self-medicated and 
45.2% made use of substances derived from plants during 
pregnancy (Glover et al., 2003). 
The aim of this study was to conduct a literature 
review on the use of herbs during pregnancy, indicating 
those that should be avoided during this period because 
of their abortifacient and/or teratogenic potential, thus 
debunking the idea that much of the population uses me-
dicinal plants that pose no risk.
With this information, health professionals, espe-
cially pharmacists working in community pharmacies may 
provide better guidance to pregnant women who visit these 
establishments often seeking natural products to relieve 
some kind of symptom.
MATERIAL AND METHODS
We carried out searches in the databases Science-
Direct, Scielo and Google Scholar. The inclusion criteria 
used were book chapters and/or complete articles (with 
abstract), available in English, Portuguese or Spanish, 
published from 1996 to 2011. The search and analysis of 
the articles were carried out in June to August of 2011 and 
written work in September to November 2011.
The descriptors used were: Medicinal Plants, Preg-
nant, Teratogenic Potential, Botanicals, Herbal Drugs, 
Natural Products, Contraindication, and the scientific 
names of some of the plants most cited in articles.
The study excluded dissertations, unavailable ar-
ticles, and papers without abstracts or in languages other 
than English, Portuguese and Spanish, as well as repeated 
articles in the databases.
Finally, the texts were analyzed to certify the verac-
ity and consistency of information needed for the research.
RESULTS AND DISCUSSION
The sample of this review was initially composed 
of 83 articles. Thirty-four articles were not included in the 
study because they did not meet the criteria for inclusion, 
leaving 49 for use in the final analysis of the work. These 
are listed according to database in Table I.
The evaluation of these studies helped achieve a sur-
vey of some medicinal plants with potentially teratogenic 
or abortifacient characteristics. The following are four of 
these plants reported, which according to Mengue et al. 
(1997) are the most commonly used as emmenagogue/
abortifacient agents by patients of the Department of 
Pre-natal Health System. The fifth most often used plant, 
Egletes viscosa (L.) Less., popularly known by the name 
of macela-da-terra, was not reported in this paper for lack 
of sufficient data in the literature on its toxicity and use 
during pregnancy.
Sena (Senna alexandrina Mill - Fabaceae): this 
plant species is part of the formulation of numerous prod-
ucts on the domestic market, both in presentations and 
simple combinations. It is mainly used in the treatment 
of constipation, and this stimulant laxative is the most 
commonly used anthranoid laxative worldwide (Robbers, 
Tyler, 1999).
It is known that constipation problems are very com-
mon in pregnant women, affecting about 38% of patients 
in this condition (Jewel, Young, 2000). In the case of 
pregnant women, the use of laxatives containing anthra-
quinones is potentially dangerous (Clarke et al., 2007), 
because the ingredients can induce uterine contractions 
(Conover, 2003), increase blood flow to the uterus and its 
attachments, increasing the risk of fetal loss, and may pass 
TABLE I - Total articles used according to database
Database Collection
Not consistent 





Scielo 43 18 25
Sciencedirect 28 10 18
Google scholar 12 6 6
TOTAL 83 34 49
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into breast milk and cause unwanted effects  such as spasms 
in the infant (Schulz et al., 2002). For the above mentioned 
reasons, products containing anthraquinones such as 
senna, should be avoided during pregnancy (Schulz et al., 
2002), especially in the first trimester, the period during 
which organogenesis occurs and during which malforma-
tions can arise from brief exposure.
Arruda (Ruta graveolens L. - Rutaceae) is a medici-
nal plant commonly used by women for contraception or 
induced abortion in Brazil and other Latin American coun-
tries (Ciganda, Laborde, 2003). It grows as a subshrub with 
yellow flowers, often cultivated in gardens, where it has 
strongly scented leaves that are greenish-white and waxy. 
It originates from countries around the Mediterranean 
basin, and in folk medicine it is recommended “to induce 
menstruation,” for a soothing feeling, to eliminate lice and 
to ward off the evil eye (Sanseverino et al., 2001). Several 
authors mention the use of this species as an abortifacient 
(Schenkel et al., 2003).
According to Ritter et al. (2002), R. graveolens is a 
plant that contains toxic substances and photosensitizers, 
which stimulate the motility of the uterus, culminating in 
abortion, cause lesions and burns on the skin and mucous 
membranes when exposed to the sun, and this damage is 
attributed to the presence of furocoumarins. Teratogenicity 
studies using this experimental plant confirm its toxicity, 
where it is induces abortion due to the presence of quino-
line alkaloids.
In mice, the ingestion of high doses of R. graveolens, 
during pre-implantation is able to induce changes in the 
blastocyst formation, reducing the number and delaying 
the development of embryos (Gutierrez-Pajares et al., 
2003). Another study, also using mice, showed no sig-
nificant difference in loss of embryos before implantation 
between the treated and control groups, but the deaths of 
fetuses of treated females suggested an embryotoxic effect 
of R. graveolens (De Freitas et al., 2005). Thus, the use 
of this medicinal plant during pregnancy was not recom-
mended by these authors.
Boldo-do-chile (Peumus boldus Molina - Monimi-
aceae) is a small tree with leaves opposite, entire, gray-
green when dry, with the upper surface rough to the touch 
and the edges slightly rolled to the bottom side. The leaves 
have numerous glands, visible to the naked eye, which 
are responsible for the characteristic aromatic odor. It is 
originally from Chile, and Brazil is an importer of dried 
leaves for medicinal use, primarily for the treatment of 
hepatic disorders in general (Sanseverino et al., 2001). 
However, animal studies showed abortive and 
teratogenic activity for the hydroalcoholic extract of 
dried leaves and also for the alkaloid boldine, one of its 
main components, in fetuses from rats previously treated. 
According to the results observed in a study by Adams 
et al. (2000), biochemical and histological changes were 
observed, which suggested moderation and care in using 
boldo during the first trimester of pregnancy, mainly due to 
lack of knowledge of the mechanisms of action produced 
by different substances in the leaves of this plant (Almeida 
et al., 2000).
Another species, also called boldo or falso boldo 
(Plectranthus barbatus (Andr.) Benth) was tested in anoth-
er study by Almeida and Lemonica (2000) with regard to 
effects on pregnancy in female rats. In folk medicine, this 
plant is widely used in Brazil as an emmenagogue and for 
termination of pregnancy. The results demonstrated that 
the treatment of rats with the highest dose of the extract of 
boldo before the period of embryo implantation caused a 
decrease in the number of implantation sites, fetal growth 
retardation, increased incidence of skeletal abnormalities 
and reduced number of ossification centers of the fetuses.
Buchinha-do-norte or cabacinha (Luffa operculata 
L. Cogn. - Cucurbitaceae) is a scandent plant, native of 
tropical America, cultivated mainly in northern and north-
eastern Brazil. The fruit is ovoid-oblong, brown when dry, 
spongy interior, consisting of a woven lattice, sometimes 
used as “vegetable sponge”. The fruit is known in folk 
medicine for its purgative effect, and recommended for 
the treatment of some parasitic diseases (Sanseverino et 
al., 2001).
Records of poisonings with L. operculata were 
performed in the Toxicological Information Center of 
Santa Catarina (SC-CIT) between 1984 and 1997. These 
poisonings occurred in ten women aged between 19 and 
26 years after ingestion of a variable amount of tea made 
with dried fruit, which is generally related to attempted 
abortion (Schenkel et al., 2003).
In another study, the decoction of L. operculata 
administered to female mice during the implantation of 
embryos caused a reduction in birth rate (Barilli et al., 
2005). Besides these four species mentioned by Mengue et 
al. (1997) as the most commonly used for abortion, there 
are several other medicinal plants that pose a potential risk 
to pregnant women.
For example, losna (Artemisia absinthium L.) when 
ingested in large amounts can cause epileptiform seizures 
and even abortion, and their use is discouraged by some 
authors (Robbers, Tyler, 1999). In this case, the toxic ac-
tion is mainly due to the presence of constituents such as 
the terpenoid thujone.
Another ingredient that when present in medicinal 
plants may make them potentially toxic substances is caf-
feine. Caffeine crosses the placental barrier and decreases 
Medicinal plants with teratogenic potential: current considerations 431
blood flow to the placenta, where it is singled out as a 
cause of weight loss in newborns, however, there is not 
consensus on this activity (Bicalho et al., 2002; Moreira 
et al., 2001).
Notably, caffeine is considered the most widely 
consumed stimulant in the world. It is estimated that 75% 
of pregnant women in the U.S. consume drinks containing 
caffeine, including other plants in this group present in 
yerba mate, black tea, green tea, cola and guarana (Bicalho 
et al., 2002).
Another commonly used plant that is dispar-
aged is potentially toxic ginger (Zingiber officinale 
Roscoe - Zingiberaceae). Tsui et al. (2001) showed 
that the main problem that pregnant women seek 
to relieve when starting a treatment with products 
of plant origin is morning sickness, and ginger has 
been used for centuries in traditional Chinese medi-
cine to relieve morning sickness in pregnant women. 
There are studies that prove their efficacy in treating nau-
sea and vomiting in pregnancy when compared with pla-
cebo, but its mechanism of action is still unclear (Marcus, 
Snodgrass, 2005; Vutyavanich et al., 2001).
Despite the already established use of ginger, a study 
showed that ginger caused embryonic loss above normal 
when administered to rats during pregnancy, but there was 
also an increase in the weight of the remaining fetuses 
(Wilkinson, 2000). This plant is taken at a dose of 2 g/day 
for the prevention of motion sickness (motion sickness) 
(WHO, 1999). However, there are many differences in 
relation to its teratogenic potential.
A study by Weidner and Sigwart (2000) found that 
an ethanol extract of ginger administered to pregnant 
rats caused no harm to either mother or developing fetus. 
Conversely, ginger components are indicated as potential 
inducers of apoptosis in human cells (Myioshi et al., 
2003). The remodeling of the fetal brain and other organs 
nevertheless involves apoptotic processes, so studies are 
needed to determine if the constituents of ginger may or 
may not interfere with these processes (Marcus, Snod-
grass, 2005).
CONCLUSION
This was a small sample of the medicinal plants 
that can be potentially toxic to pregnant women, re-
futing the idea that natural products do not pose any 
health risk. Regarding the safety of these products dur-
ing pregnancy, information and reliable data are scarce 
and often contradictory. In this sense, it is critical to 
conduct studies like the present work, which provides 
an overview of what we have available in the literature. 
Health care professionals, especially pharmacists, need to 
guide pregnant women in their use of any product of plant 
origin, without prior consent of their physician, noting the 
danger of self-medication, and clarify the risks involved in 
using medicinal plants without proper guidance.
Along this line, it is essential to continue the devel-
opment of studies on the efficacy, effectiveness and safety 
of natural products and herbal medicines, to determine 
their rational use.
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